title: Detection of EGFR mutations in the plasma of patients with lung adenocarcinoma for real-time monitoring of therapeutic response to tyrosine kinase inhibitors?
authors.affiliation: Department of Pneumology, La Roche sur Yon Hospital, La Roche sur Yon, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Marcq
authors.affiliation: Department of Biochemistry, Nantes University Hospital, Nantes, France.
authors.forename: Audrey
authors.initials: A
authors.lastname: Vallée
authors.affiliation: Department of Pneumology, La Roche sur Yon Hospital, La Roche sur Yon, France.
authors.forename: Acya
authors.initials: A
authors.lastname: Bizieux
authors.affiliation: Department of Biochemistry, Nantes University Hospital, Nantes, France. Electronic address: marc.denis@chu-nantes.fr.
authors.forename: Marc G
authors.initials: MG
authors.lastname: Denis
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D000368:Aged; D004273:DNA, Neoplasm / Q000097:blood*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
chemical_list: D004273:DNA, Neoplasm; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases